The article also questions the grand ambitions of Altman and Huffington, as the product is still in its conceptual stage with no launch date provided. It highlights the potential risks of data misuse and the lack of clarity on how the product will actually function. The author expresses skepticism about the promises made by the founders and the potential impact of the product on the healthcare system.
Key takeaways:
- Sam Altman and Arianna Huffington have announced the launch of a new company, Thrive AI Health, which aims to use OpenAI’s technology to assess health data and make recommendations.
- The company's ambitions are to improve health outcomes, reduce health-care costs, and significantly reduce the effects of chronic disease worldwide.
- There are concerns about the privacy implications of AI in health, with the potential for companies to train their models on hyper-personal, confidential information.
- The article suggests skepticism about the promises of AI in health, arguing that the technology's most consequential effects are always just on the horizon, never in the present.